MedTrace Logo

Allocating Resources for Cancer Care in Times of the Sars-CoV-2 Outbreak. Health Care Research

NCT05479292 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6500

Last updated 2022-07-29

No results posted yet for this study

Summary

The focus on treatment of COVID19 patients during the Sars-CoV-2 outbreak has most likely implications for the extent and quality of diagnosis and treatment of non-COVID19 patients. Medical care of cancer patients is a particularly sensitive area. To draw holistic conclusions, it is necessary to analyze the provision of healthcare as broadly as possible with regard to the dimensions of access, processes and outcome during the Sars-CoV-2 pandemic. This will be implemented exemplarily for the early detection, diagnosis and treatment of colorectal cancer (CRC) and pancreatic cancer (PaCa) in Saxony. Patients with diagnosis, treatment or early detection measures for type 2 diabetes (T2D), coronary heart disease (CHD) and multiple sclerosis (MS) serve as comparison groups.

Conditions

  • Colorectal Cancer (CRC) and Pancreatic Cancer (PaCa)

Interventions

OTHER

Sars-CoV-2 outbreak

Sars-CoV-2 pandemic's impact on provision of healthcare for cancer patients

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • AOK PLUS

    collaborator INDUSTRY

  • Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg

    collaborator UNKNOWN

  • Ruhr-Universität Bochum

    collaborator UNKNOWN

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Jochen Schmitt, Dr. med. · Technische Universität Dresden

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05479292 on ClinicalTrials.gov